OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: GAP Innovations, PBC

1 Projects | 1 Researchers | $1,500,000 Invested

2021

GAP Innovations, PBC

Doug Beauregard

Development of a Biosample Database to Investigate Beta-Amyloid (Aß), Phospho-Tau (P-tau), and Neurofilament Light Chain (NfL) Blood-Based and Digital Biomarkers in Older Volunteers Screened for Preclinical Alzheimer’s Disease (AD), Prodromal AD, or Mild AD.

  • Funding Amount: $1,500,000
  • Organization Type: Biotechnology/For Profit
  • Program: Biomarkers
  • Target: Neuronal Degeneration
  • Status: Active